Gradient Investments LLC Abb Vie Inc. Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

A detailed history of Gradient Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gradient Investments LLC holds 77,565 shares of ABBV stock, worth $14 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

77,565

Previous 95,207 18.53%

Holding current value

$14 Million

Previous $16.3 Million 6.2%

% of portfolio

0.4%

Previous 0.47%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $2.89 Million - $3.52 Million	-17,642 Reduced 18.53%	77,565 $15.3 Million
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $204,322 - $238,603	1,320 Added 1.41%	95,207 $16.3 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $13.5 Million - $15.4 Million	84,448 Added 894.67%	93,887 $17.1 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $12,934 - $14,567	-94 Reduced 0.99%	9,439 $1.46 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $255,023 - $295,226	-1,909 Reduced 16.68%	9,533 $1.42 Million
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $524,474 - $652,674	-3,958 Reduced 25.7%	11,442 $1.54 Million
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $4,193 - $4,829	29 Added 0.19%	15,400 $2.45 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $1,521 - $1,824	11 Added 0.07%	15,371 $0
Q3 2022 Oct 14, 2022	BUY	$134.21 - $153.93 $26,305 - $30,170	196 Added 1.29%	15,360 $2.06 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $127,986 - $162,712	930 Added 6.53%	15,164 $2.32 Million
Q1 2022 May 26, 2022	SELL	$131.98 - $163.75 $39,989 - $49,616	-303 Reduced 2.08%	14,234 $2.31 Million
Q4 2021 Jan 12, 2022	BUY	$107.43 - $135.93 $650,166 - $822,648	6,052 Added 71.33%	14,537 $1.97 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $10.6 Million - $12 Million	-99,303 Reduced 92.13%	8,485 $915,000
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $320,154 - $356,670	3,043 Added 2.91%	107,788 $12.1 Million
Q1 2021 Apr 21, 2021	SELL	$102.3 - $112.62 $204 - $225	-2 Reduced -0.0%	104,745 $11.3 Million
Q4 2020 Jan 08, 2021	SELL	$80.49 - $108.67 $102,705 - $138,662	-1,276 Reduced 1.2%	104,747 $9.18 Million
Q3 2020 Oct 06, 2020	SELL	$85.91 - $100.83 $217,352 - $255,099	-2,530 Reduced 2.33%	106,023 $9.29 Million
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $474,043 - $634,340	-6,461 Reduced 5.62%	108,553 $10.7 Million
Q1 2020 Apr 07, 2020	SELL	$64.5 - $97.79 $24,316 - $36,866	-377 Reduced 0.33%	115,014 $8.76 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $1.25 Million - $1.56 Million	-17,286 Reduced 13.03%	115,391 $10.2 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $473,672 - $569,490	7,521 Added 6.01%	132,677 $10 Million
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $1.86 Million - $2.38 Million	28,385 Added 29.33%	125,156 $9.1 Million
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $355,461 - $418,360	-4,608 Reduced 4.55%	96,771 $7.8 Million
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $45,931 - $56,645	590 Added 0.59%	101,379 $9.35 Million
Q3 2018 Oct 11, 2018	BUY	$88.91 - $98.84 $1.69 Million - $1.88 Million	19,036 Added 23.28%	100,789 $9.53 Million
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $630,255 - $745,734	7,020 Added 9.39%	81,753 $7.57 Million
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $942,274 - $1.26 Million	-10,241 Reduced 12.05%	74,733 $7.07 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $1.7 Million - $1.86 Million	-18,988 Reduced 18.26%	84,974 $8.22 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $7.26 Million - $9.28 Million	103,962	103,962 $9.24 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Abb Vie Inc. Transaction History